MUC16 and cancer: In cancer diagnosis, nanobodies can detect biomarkers like Cancer Antigen 125 (CA125), Prostate-Specific Antigen (PSA), and Alpha-Fetoprotein (AFP) with high sensitivity, enabling early screening, diagnosis, and monitoring of disease progression [56,57,58].